Brian J. Reid
#143,629
Most Influential Person Now
Brian J. Reid's AcademicInfluence.com Rankings
Brian J. Reidbiology Degrees
Biology
#10295
World Rank
#13610
Historical Rank
Developmental Biology
#128
World Rank
#136
Historical Rank
Cell Biology
#480
World Rank
#492
Historical Rank
Genetics
#1080
World Rank
#1179
Historical Rank
Download Badge
Biology
Brian J. Reid's Degrees
- PhD Molecular Biology University of California, Berkeley
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Brian J. Reid Influential?
(Suggest an Edit or Addition)Brian J. Reid's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genetic control of the cell division cycle in yeast. (1974) (1689)
- Cancer as an evolutionary and ecological process (2006) (1580)
- Observer variation in the diagnosis of dysplasia in Barrett's esophagus. (1988) (768)
- Early detection: The case for early detection (2003) (703)
- Genetic clonal diversity predicts progression to esophageal adenocarcinoma (2006) (688)
- An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. (1993) (596)
- A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. (2004) (556)
- Genetic control of the cell-division cycle in yeast. I. Detection of mutants. (1970) (532)
- Evolution of neoplastic cell lineages in Barrett oesophagus (1999) (468)
- Overdiagnosis and overtreatment in cancer: an opportunity for improvement. (2013) (466)
- Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets (2000) (460)
- Addressing overdiagnosis and overtreatment in cancer: a prescription for change. (2014) (414)
- Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. (1988) (404)
- Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis (2010) (367)
- 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. (1996) (344)
- p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. (2001) (292)
- Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. (2000) (289)
- Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. (1992) (286)
- Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. (1987) (281)
- Effect of Segment Length on Risk for Neoplastic Progression in Patients with Barrett Esophagus (2000) (278)
- Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables (2001) (274)
- Barrett's esophagus and esophageal adenocarcinoma. (1991) (273)
- Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward (2006) (272)
- NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma (2007) (259)
- Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression (2001) (249)
- Selectively Advantageous Mutations and Hitchhikers in Neoplasms (2004) (236)
- Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. (1992) (235)
- Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. (2000) (235)
- Progression to cancer in Barrett's esophagus is associated with genomic instability. (1989) (233)
- Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. (2000) (220)
- Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. (2005) (218)
- Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort (1992) (215)
- p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. (1997) (198)
- The Combination of Genetic Instability and Clonal Expansion Predicts Progression to Esophageal Adenocarcinoma (2004) (197)
- Hereditary Gastrointestinal Polyposis Syndromes (1986) (188)
- Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. (1993) (187)
- Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. (1996) (186)
- p53-mutant clones and field effects in Barrett's esophagus. (1999) (185)
- Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. (2000) (181)
- Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia (2000) (180)
- A Genome-Wide Association Study Identifies New Susceptibility Loci for Esophageal Adenocarcinoma and Barrett’s Esophagus (2013) (179)
- Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett’s esophagus (2012) (176)
- Comparative genomic analysis of tumors: detection of DNA losses and amplification. (1995) (172)
- p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. (1994) (165)
- Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. (2001) (162)
- A Comprehensive Survey of Clonal Diversity Measures in Barrett's Esophagus as Biomarkers of Progression to Esophageal Adenocarcinoma (2010) (161)
- Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. (1993) (157)
- Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. (1992) (157)
- Regulation of mating in the cell cycle of Saccharomyces cerevisiae (1977) (153)
- Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. (1994) (152)
- 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. (1994) (151)
- Leukocyte Telomere Length Predicts Cancer Risk in Barrett's Esophagus (2007) (150)
- 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. (1991) (148)
- Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. (1991) (142)
- Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. (2014) (142)
- Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. (1996) (139)
- Crypt Dysplasia With Surface Maturation: A Clinical, Pathologic, and Molecular Study of a Barrett's Esophagus Cohort (2006) (138)
- Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. (1991) (137)
- Barrett's esophagus: ordering the events that lead to cancer. (1996) (137)
- Focus on Barrett's esophagus and esophageal adenocarcinoma. (2004) (130)
- Temporal and Spatial Evolution of Somatic Chromosomal Alterations: A Case-Cohort Study of Barrett's Esophagus (2013) (130)
- Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma. (2013) (123)
- Progressive Region-Specific De Novo Methylation of the p16 CpG Island in Primary Human Mammary Epithelial Cell Strains during Escape from M0 Growth Arrest (1999) (120)
- Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus (2000) (109)
- Extent of Low-Grade Dysplasia Is a Risk Factor for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus (2007) (109)
- Chromosomal Instability and Copy Number Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma (2009) (104)
- Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. (2002) (103)
- Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. (1988) (103)
- Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. (1996) (100)
- Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. (2013) (100)
- Barrett's esophagus and adenocarcinoma. (1987) (95)
- Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus (2015) (93)
- Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett’s Esophagus Cohort (2015) (93)
- Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. (1991) (92)
- Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus (2000) (91)
- Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs (2020) (90)
- The Role of Tobacco, Alcohol, and Obesity in Neoplastic Progression to Esophageal Adenocarcinoma: A Prospective Study of Barrett's Esophagus (2013) (88)
- Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity. (2004) (87)
- Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. (1998) (82)
- The management of high grade dysplasia and early cancer in Barrett's esophagus (1994) (78)
- Endoscopic biopsy technique for acquiring larger mucosal samples. (1991) (77)
- Single Nucleotide Polymorphism–Based Genome-Wide Chromosome Copy Change, Loss of Heterozygosity, and Aneuploidy in Barrett's Esophagus Neoplastic Progression (2008) (76)
- Biomarkers in Barrett's esophagus. (2003) (76)
- Biologic Properties of Columnar Epithelium Underneath Reepithelialized Squamous Mucosa in Barrett's Esophagus (2005) (74)
- Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. (1989) (73)
- Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array‐CGH (2007) (73)
- Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR. (1999) (73)
- Molecular phenotype of spontaneously arising 4N (G2-tetraploid) intermediates of neoplastic progression in Barrett's esophagus. (2003) (72)
- Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. (2003) (68)
- Biomarkers in Barrett esophagus. (2001) (68)
- Cell Proliferation, Cell Cycle Abnormalities, and Cancer Outcome in Patients with Barrett's Esophagus: A Long-term Prospective Study (2008) (68)
- Persistent clonal areas and clonal expansion in Barrett's esophagus. (1992) (66)
- Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues. (2006) (64)
- Chromosomal Instability in Barrett's Esophagus Is Related to Telomere Shortening (2006) (64)
- NSAIDs Modulate Clonal Evolution in Barrett's Esophagus (2013) (64)
- Natural selection in neoplastic progression of Barrett's esophagus. (2005) (60)
- Neosquamous Epithelium Does Not Typically Arise from Barrett's Epithelium (2006) (60)
- Use of Statin Medications and Risk of Esophageal Adenocarcinoma in Persons with Barrett's Esophagus (2012) (59)
- Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. (2017) (56)
- Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus. (2003) (52)
- Dietary Supplement Use and Risk of Neoplastic Progression in Esophageal Adenocarcinoma: A Prospective Study (2007) (51)
- Barrett's esophagus: a model of human neoplastic progression. (1994) (51)
- p53 and neoplastic progression in barrett's esophagus (2001) (51)
- Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae. (2002) (47)
- Deletion at Fragile Sites Is a Common and Early Event in Barrett's Esophagus (2010) (46)
- Nonadenomatous Dysplasia in Barrett Esophagus: A Clinical, Pathologic, and DNA Content Flow Cytometric Study (2009) (45)
- Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus. (2006) (43)
- Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer. (2002) (43)
- Inflammation and Oxidative Stress Markers and Esophageal Adenocarcinoma Incidence in a Barrett's Esophagus Cohort (2014) (43)
- Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus (2015) (42)
- Longitudinal Study of Insulin-like Growth Factor, Insulin-like Growth Factor Binding Protein-3, and their Polymorphisms: Risk of Neoplastic Progression in Barrett's Esophagus (2007) (41)
- Evolution of Barrett’s esophagus through space and time at single-crypt and whole-biopsy levels (2018) (39)
- Genetic Mechanisms of TP53 Loss of Heterozygosity in Barrett's Esophagus: Implications for Biomarker Validation (2006) (39)
- Genotypic analysis of multiple loci in somatic cells by whole genome amplification. (1995) (39)
- Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. (2014) (38)
- p16 Mutation Spectrum in the Premalignant Condition Barrett's Esophagus (2008) (38)
- Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium. (1989) (37)
- Waist-to-Hip Ratio, Weight Gain, and Dietary and Serum Selenium Are Associated With DNA Content Flow Cytometry in Barrett's Esophagus (2000) (36)
- Translational Research Working Group Developmental Pathway for Biospecimen-Based Assessment Modalities (2008) (36)
- Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases (2019) (35)
- Inactivation of p53 and the Development of Tetraploidy in the Elastase‐SV40 T Antigen Transgenic Mouse Pancreas (1995) (35)
- Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium (1989) (35)
- Warburg and Crabtree Effects in Premalignant Barrett's Esophagus Cell Lines with Active Mitochondria (2013) (34)
- Mutagen Sensitivity and Neoplastic Progression in Patients with Barrett's Esophagus: A Prospective Analysis (2006) (34)
- New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management. (2011) (34)
- Low-Fat, High Fruit and Vegetable Diets and Weight Loss Do Not Affect Biomarkers of Cellular Proliferation in Barrett Esophagus (2005) (31)
- Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage (2014) (30)
- Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma. (2015) (29)
- Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. (2014) (28)
- Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay (1990) (26)
- Esophageal Adenocarcinoma and Its Rare Association with Barrett’s Esophagus in Henan, China (2014) (26)
- Selenium, Selenoenzymes, Oxidative Stress and Risk of Neoplastic Progression from Barrett's Esophagus: Results from Biomarkers and Genetic Variants (2012) (26)
- Application of Biomarkers in Cancer Risk Management: Evaluation from Stochastic Clonal Evolutionary and Dynamic System Optimization Points of View (2011) (24)
- High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett’s Esophagus (2015) (24)
- High-quality RNA and DNA from flow cytometrically sorted human epithelial cells and tissues. (2002) (24)
- Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett’s esophagus, and high-grade dysplasia/esophageal adenocarcinoma (2017) (24)
- Endoscopic Diagnosis of Esophageal Neoplasms (1992) (23)
- MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium (2015) (23)
- Loss of heterozygosity in childhood de novo acute myelogenous leukemia. (2001) (22)
- A Newly Identified Susceptibility Locus near FOXP1 Modifies the Association of Gastroesophageal Reflux with Barrett's Esophagus (2015) (20)
- Direct Inference of SNP Heterozygosity Rates and Resolution of LOH Detection (2007) (20)
- Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening (2016) (20)
- Early events during neoplastic progression in Barrett's esophagus. (2010) (19)
- Obesity and inflammation markers in relation to leukocyte telomere length in a cross-sectional study of persons with Barrett’s esophagus (2015) (17)
- Flow-cytometric DNA content analysis of esophageal squamous cell carcinomas. (1991) (16)
- NSAID use and somatic exomic mutations in Barrett’s esophagus (2018) (16)
- Polymorphisms Near TBX 5 and GDF 7 Are Associated With Increased Risk for Barrett ’ s Esophagus (14)
- Novel patterns of complex structural variation revealed across thousands of cancer genome graphs (2019) (14)
- Actinic granuloma in association with giant cell arteritis: Are both caused by sunlight? (1997) (13)
- Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus (2018) (13)
- Barrett's esophagus: the biology of neoplastic progression. (1994) (13)
- High yields of RNA and DNA suitable for array analysis from cell sorter purified epithelial cell and tissue populations (1999) (12)
- Progressive Region-Specific De Novo Methylation of the p16 CpG Island in Primary Human Mammary Epithelial Cell Strains during Escape from M 0 Growth Arrest (1999) (12)
- No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. (2019) (12)
- Role of endoscopic ultrasound in patients with Barrett's esophagus and high grade dysplasia (1997) (11)
- Flow cytometric enrichment for respiratory epithelial cells in sputum (2004) (11)
- Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity. (2009) (10)
- A low-cost fiber-optic instrument to colorimetrically detect patients with Barrett's esophagus for early detection of esophageal adenocarcinoma (2001) (10)
- Neoplastic Progression in Barrett’s Esophagus (1997) (9)
- Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett’s Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium (2015) (9)
- Limitations of the Driver/Passenger Model in Cancer Prevention (2016) (8)
- Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. (2019) (8)
- Feasibility of RNA and DNA Extraction from Fresh Pipelle and Archival Endometrial Tissues for Use in Gene Expression and SNP Arrays (2013) (8)
- Flow Cytometric Changes That Precede Cancer: Premalignant Gastrointestinal Disease (1989) (8)
- Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. (2020) (8)
- Quantification of Multiple Tumor Clones Using Gene Array and Sequencing Data. (2017) (7)
- Somatic evolution in neoplastic progression and cancer prevention (2011) (7)
- Forty-five years of cell-cycle genetics (2015) (7)
- Allelic Deletions and p 53 Protein Overexpression in Barrett ' s Adenocarcinoma 1 (2006) (6)
- Somatic whole genome dynamics of precancer in Barrett’s esophagus reveals features associated with disease progression (2021) (6)
- Complete regression of high-grade dysplasia, DNA content abnormalities, and Barrett's esophagus (1995) (5)
- Predictors of progression in Barrett's esophagus: Baseline 17p (p53) loss of heterozygesity identifies a patient subset at increased risk for neoplastic progressies (2001) (5)
- Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective (2017) (4)
- Evolution of Barrett’s esophagus through space and time at single-crypt and whole-biopsy levels (2018) (4)
- NSAID and oesophageal adenocarcinoma: randomised trials needed to correct for bias – Authors' reply (2006) (4)
- Platform for combined analysis of functional and biomolecular phenotypes of the same cell (2017) (4)
- Accuracy of endoscopic ultrasound staging in patients with Barrett's esophagus and intramucosal carcinoma (1997) (4)
- Cancer Risk Assessment and Cancer Prevention: Promises and Challenges (2008) (3)
- Correction: Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China (2015) (3)
- Has cancer sculpted the genome? Modeling linkage and the role of tetraploidy in neoplastic progression (2010) (3)
- Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus (2022) (2)
- Early Diagnosis of Gastroesophageal Cancers and the Cytosponge: A Work in Progress (2017) (2)
- Transcriptional analysis of Barrett's epithelium and normal gastrointestinal tissues (2001) (2)
- Novel low-cost fiber optic colorimetric instrument to rapidly screen premalignant esophageal tissue (1998) (2)
- Barrett's Esophagus and Esophageal Adenocarcinoma Epigenetic Biomarker Discovery Using Infinium ® Methylation (2008) (2)
- T1932 Basal Crypt Dysplasia Is Highly Associated with Conventional Dysplasia in Barretts Esophagus: A Seattle Cohort Study of 101 Patients (2009) (2)
- Within‐patient phylogenetic reconstruction reveals early events in Barrett’s Esophagus (2020) (2)
- Quantification of population benefit in evaluation of biomarkers: practical implications for disease detection and prevention (2014) (2)
- Clonal cell populations with p16 lesions arise early and expand within Barrett's metaplastic epithelium (2001) (2)
- Developmental Pathway for Biospecimen-Based Assessment Modalities (2008) (2)
- Reflection and Reaction (2006) (2)
- Translational ResearchWorking Group Developmental Pathway for Biospecimen-Based AssessmentModalities (2008) (1)
- 1 SNP-based Genome-wide Chromosome Copy Change , LOH , and Aneuploidy in Barrett ’ s Esophagus Neoplastic Progression . (2008) (1)
- Author Correction: Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases (2019) (1)
- T1897 Conversion of Goblet to Non-Goblet Columnar Metaplasia of the Esophagus. a Clinical/Pathologic and Molecular Study of 10 Cases (2009) (1)
- Survey of Clonal Diversity Measures in rett ' s Esophagus as Biomarkers of Progression to Pr R phageal Adenocarcinoma (2010) (0)
- Comparative genomic analysis of tumors: Detection of DNA losses (2005) (0)
- Transcriptional analysis of tetraploid epithelial cells in Barrett's esophagus (2001) (0)
- Association of Eosinophilic Esophagitis and Persistent Esophagitis in Barrett's Esophagus (2011) (0)
- Abstract B48: Cross sectional analysis of copy loss in Barrett’s Esophagus (2008) (0)
- Characterization of genetic heterogeneity in neoplastic progression (2007) (0)
- Nonsteroidal Anti-inflammatory Drug Use , Body Mass Index , and Anthropometry in Relation to Genetic and Flow Cytometric Abnormalities in Barrett ’ s Esophagus 1 (2002) (0)
- Correction to: NSAID use and somatic exomic mutations in Barrett’s esophagus (2019) (0)
- Temporal Change in Barrett's Esophagus Segment Length (BESL) During Prospective Surveillance (2004) (0)
- Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett’s esophagus, and high-grade dysplasia/esophageal adenocarcinoma (2017) (0)
- Benign Cell Boosters: Exploring Novel Cancer Therapies Through Simulation (1976) (0)
- Predictors of progression to cancer in Barrett's esophagus (BE): Endoscopic lesions arising from Barrett's epithelium are not independently associated with increased risk (2003) (0)
- Surrogate Markers: Lessons from the Next Gen? (2016) (0)
- Expression analysis of Barrett's epithelium and normal gastrointestinal tissues (2000) (0)
- Allelic imbalance in routinely processed breast tumors determined by affymetrix HuSNP array (2001) (0)
- Abstract PR10: Identification of novel candidate serum metabolite biomarkers for distinguishing between gastro-esophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma (2015) (0)
- BASIC AND TRANSLATIONAL—ALIMENTARY TRACT Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus (2015) (0)
- Barrett's esopbagus (1998) (0)
- Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage (2014) (0)
- The effects of calendar year, age and acid suppression medication on the amount of change in Barrett's esophagus surface area. (2006) (0)
- Changing the terminology of cancer--reply. (2014) (0)
- Correction to: NSAID use and somatic exomic mutations in Barrett’s esophagus (2019) (0)
- Abstract PR-03: A prospective study of systemic markers of inflammation and risk of esophageal adenocarcinoma in a Barrett's esophagus cohort (2011) (0)
- Whole genome analysis of copy number changes in Barrett's esophagus and esophageal adenocarcinoma. (2006) (0)
- Abstract A60: Use of statin medications and reduced risk of esophageal adenocarcinoma in persons with Barrett's esophagus (2010) (0)
- Abstract CN06-03: Disease dynamics: Cancers evolving fast and slow or not at all (2015) (0)
- Allelic imbalance in routinely processed breast tumors determined by Affymetrix HuSNP array (2001) (0)
- Contrary to Prevailing Wisdom, the Risk of Adenocarcinoma is Inversely Proportional to the Number of Goblet Cells in Patients With Barrett's Esophagus (2011) (0)
- Advances in Brief l 7 p Allelic Losses in Diploid Cells of Patients with Barrett ' s Esophagus Who Develop Aneuploidy ' (2006) (0)
- Fish as an alternative test for LOH in Barrett's esophagus: implications for the mechanism of p53 loss (2003) (0)
- Histopathology of Barrett's esophagus. Features relevant to clinical management (1997) (0)
- CommentaryCancer Prevention Research Cancer Risk Assessment and Cancer Prevention : Promises and Challenges (2008) (0)
- A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization (2021) (0)
- NSAID use and somatic exomic mutations in Barrett’s esophagus (2018) (0)
- P16 alterations mediate clonal expansion and bypass tumor suppressor mechanisms in Barrett's intestinal metaplasia (2003) (0)
- Abstract A74: Cohort study of obesity, tobacco, and alcohol and risk of neoplastic progression to esophageal adenocarcinoma in Barrett's esophagus (2010) (0)
- University of Birmingham Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus (0)
- Esophageal Adenocarcinomas and Aneuploid Cell Populations of Barrett ' s-associated Microsatellite Instability Occurs Frequently and in Both Diploid Updated (2006) (0)
- PATRICIA L. BLOUNT*t, STEPHEN J. MELTZERt, JING YINt, YING HUANGt, MARK J. KRASNA?, (2016) (0)
- Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma within the Seattle Barrett's esophagus study. (2006) (0)
- Dysplasia and High-Grade (1994) (0)
- Genetic Variation in Selenoenzymes and Their Activity (2010) (0)
- Abstract LB-027: Single-cell analysis of functional heterogeneity dynamics in premalignant progression revealed by combined interrogation of functional and transcriptional phenotypes (2016) (0)
- Undergo Clonal Expansion in Barrett ' s Metaplastic Epithelium Lesions Are Common , Early Abnormalities thatINK 4 a p 16 Updated (2001) (0)
- Integrated genomic characterization of oesophageal carcinoma (2017) (0)
- TRWG developmental pathway for biospecimen-based assessment modalities (2008) (0)
- Genome-wide case study of clonal evolution over 16 years in Barrett's Esophagus. (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Brian J. Reid?
Brian J. Reid is affiliated with the following schools:
